Catalyst Pharmaceuticals Inc (CPRX)
21.63
-0.11
(-0.51%)
USD |
NASDAQ |
Nov 05, 11:16
Catalyst Pharmaceuticals Free Cash Flow: 114.96M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | 114.96M |
| March 31, 2024 | 81.59M |
| December 31, 2023 | 61.86M |
| September 30, 2023 | 48.60M |
| June 30, 2023 | 124.13M |
| March 31, 2023 | 119.54M |
| December 31, 2022 | 116.02M |
| September 30, 2022 | 95.08M |
| June 30, 2022 | 75.41M |
| March 31, 2022 | 64.93M |
| December 31, 2021 | 59.35M |
| September 30, 2021 | 53.32M |
| June 30, 2021 | 43.12M |
| March 31, 2021 | 40.71M |
| December 31, 2020 | 45.02M |
| September 30, 2020 | 44.21M |
| June 30, 2020 | 49.03M |
| March 31, 2020 | 49.83M |
| December 31, 2019 | 34.59M |
| September 30, 2019 | 13.89M |
| June 30, 2019 | -9.346M |
| March 31, 2019 | -28.18M |
| December 31, 2018 | -26.24M |
| September 30, 2018 | -21.86M |
| June 30, 2018 | -17.52M |
| Date | Value |
|---|---|
| March 31, 2018 | -15.95M |
| December 31, 2017 | -13.74M |
| September 30, 2017 | -14.13M |
| June 30, 2017 | -14.78M |
| March 31, 2017 | -16.01M |
| December 31, 2016 | -18.06M |
| September 30, 2016 | -18.27M |
| June 30, 2016 | -20.35M |
| March 31, 2016 | -20.17M |
| December 31, 2015 | -18.04M |
| September 30, 2015 | -17.40M |
| June 30, 2015 | -15.61M |
| March 31, 2015 | -14.36M |
| December 31, 2014 | -13.00M |
| September 30, 2014 | -13.14M |
| June 30, 2014 | -11.25M |
| March 31, 2014 | -10.07M |
| December 31, 2013 | -9.885M |
| September 30, 2013 | -7.394M |
| June 30, 2013 | -6.811M |
| March 31, 2013 | -6.145M |
| December 31, 2012 | -5.193M |
| September 30, 2012 | -4.994M |
| June 30, 2012 | -5.145M |
| March 31, 2012 | -5.464M |
Free Cash Flow Range, Past 5 Years
34.59M
Minimum
Dec 2019
124.13M
Maximum
Jun 2023
69.54M
Average
59.35M
Median
Dec 2021
Free Cash Flow Benchmarks
| Sarepta Therapeutics Inc | -527.92M |
| Vertex Pharmaceuticals Inc | -1.426B |
| Regenxbio Inc | -194.72M |
| Edgewise Therapeutics Inc | -104.72M |
| Entrada Therapeutics Inc | -18.50M |